About this condition
After a stroke, patients may seek support for their rehabilitation. Suitability depends on time since the event and overall stability.
How we approach it
Neurological cases receive an extended records review. Protocols are investigational and designed to complement care from your neurologist.
Therapies we may consider
How to prepare
- •Gather your records: diagnosis letters, recent lab results, imaging reports (MRI, X-ray, CT) and a medication list.
- •Keep taking prescribed medication — we never ask you to stop treatment from your own doctor.
- •Ask your specialist whether they are willing to share notes with our physicians; coordinated care is safer.
- •Write down your main goals and current symptoms (for example, pain on a 0–10 scale or walking distance) so we can measure change honestly.
- •Plan your trip: most programs need 2–5 days in Los Cabos, and you should avoid long flights for 24 hours after joint procedures if possible.
Possible side effects
Depends on the therapy your physician recommends. Most are mild and short-lived.
Mesenchymal Stem Cells
- · Mild fatigue, low-grade fever or chills in the first 24–48 hours after infusion
- · Headache or mild nausea
- · Soreness, swelling or stiffness at the injection site for a few days (joint injections)
- · Bruising at the IV site
Hyperbaric & Red Light
- · Ear pressure or discomfort (most common with HBOT)
- · Temporary sinus pressure
- · Fatigue after sessions
- · Temporary short-sightedness during long HBOT series, which normally resolves weeks after finishing
Selected published research
Hyperbaric oxygen induces late neuroplasticity in post-stroke patients
Efrati S et al., PLoS One, 2013
Improved neurological function in chronic stroke patients after HBOT.
Mesenchymal stem cell transplantation in multiple sclerosis: phase I/II trials
Multiple authors, incl. Connick P et al., Lancet Neurol, 2012
Early trials showed the approach was safe with some signs of benefit on vision and imaging measures.
Stem cell therapies for Parkinson's disease and neurodegeneration: reviews
Multiple authors
Research is at an early stage; results are preliminary and not yet practice-changing.
Links open PubMed or the original source. Study results do not guarantee individual outcomes.
What the evidence says
Research is early-stage. Protocols are offered on an investigational basis after thorough physician review.
We do not promise cures or specific outcomes. Read our safety & eligibility page.
Wondering if you're a candidate?
A physician will review your records and give you an honest answer.
Book a Consultation